Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models

Food and Chemical Toxicology ◽

10.1016/j.fct.2021.112000 ◽

2021 ◽

Vol 149 ◽

pp. 112000

Author(s):

Ryeo-Eun Go ◽

Cho-Won Kim ◽

Sung-Moo Lee ◽

Hong Kyu Lee ◽

Kyung-Chul Choi

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Growth ◽

Growth And Survival ◽

Download Full-text

Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models

Environmental Toxicology ◽

10.1002/tox.22337 ◽

2016 ◽

Vol 32 (4) ◽

pp. 1439-1454 ◽

Author(s):

Ryeo-Eun Go ◽

Cho-Won Kim ◽

So-Ye Jeon ◽

Yong-Sub Byun ◽

Eui-Bae Jeung ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Epithelial Mesenchymal Transition ◽

Cancer Growth ◽

Mesenchymal Transition ◽

Cancer Models ◽

Dependent Pathway

Download Full-text

Abstract 3133: Clonal facilitation drives estrogen receptor positive (ER+) breast cancer growth and survival

10.1158/1538-7445.am2021-3133 ◽

2021 ◽

Author(s):

Rena Emond ◽

Vince K. Grolmusz ◽

Jason Griffiths ◽

Jinfeng Chen ◽

Frederick R. Adler ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Growth ◽

Growth And Survival ◽

Estrogen Receptor Positive ◽

Breast Cancer Growth

Download Full-text

Faculty Opinions recommendation of Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4410956.7111061 ◽

2010 ◽

Author(s):

Sandra Davidge ◽

Stephane Bourque

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Estrogen Receptor Alpha ◽

Cancer Growth ◽

Cardiovascular Protection ◽

Receptor Alpha ◽

Nuclear Estrogen Receptor ◽

Breast Cancer Growth

Download Full-text

Faculty Opinions recommendation of Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4410956.6051054 ◽

2010 ◽

Author(s):

Dariusz J Skarzynski ◽

Marta Siemieniuch

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Estrogen Receptor Alpha ◽

Cancer Growth ◽

Cardiovascular Protection ◽

Receptor Alpha ◽

Nuclear Estrogen Receptor ◽

Breast Cancer Growth

Download Full-text

Abstract PS17-16: Sar439859, a novel selective estrogen receptor degrader (serd), demonstrates effective and broad antitumor activity in wild-type and mutant er-positive breast cancer models

10.1158/1538-7445.sabcs20-ps17-16 ◽

2021 ◽

Author(s):

Maysoun Shomali ◽

Fangxian Sun ◽

Mikhail Levit ◽

Jack Pollard ◽

Joon Sang Lee ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Antitumor Activity ◽

Wild Type ◽

Cancer Models ◽

Er Positive ◽

Positive Breast Cancer

Download Full-text

Organophosphate ester tri-o-cresyl phosphate interacts with estrogen receptor α in MCF-7 breast cancer cells promoting cancer growth

Toxicology and Applied Pharmacology ◽

10.1016/j.taap.2020.114977 ◽

2020 ◽

Vol 395 ◽

pp. 114977 ◽

Author(s):

Madeleine Böckers ◽

Norbert W. Paul ◽

Thomas Efferth

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Estrogen Receptor Α ◽

Cancer Growth ◽

Download Full-text

Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin

Breast Cancer Research ◽

10.1186/bcr2586 ◽

2010 ◽

Vol 12 (3) ◽

Author(s):

Kathryn E Vanderlaag ◽

Susan Hudak ◽

Laura Bald ◽

Laurence Fayadat-Dilman ◽

Manjiri Sathe ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cell Growth ◽

Cyclin D1 ◽

Breast Cancer Cell ◽

Critical Role ◽

Estrogen Receptor Α ◽

Cancer Cell Growth ◽

Growth And Survival ◽

Breast Cancer Cell Growth

Download Full-text

Abstract PD01-06: Inhibition of the Ret receptor tyrosine kinase in combination with endocrine therapy impacts on migration and metastatic potential of estrogen receptor positive breast cancer models.

10.1158/0008-5472.sabcs12-pd01-06 ◽

2012 ◽

Author(s):

NE Hynes ◽

A Gattelli ◽

I Nalvarte ◽

T Roloff

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Tyrosine Kinase ◽

Endocrine Therapy ◽

Receptor Tyrosine Kinase ◽

Metastatic Potential ◽

Cancer Models ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Abstract LB-166: PARP inhibition effects on endocrine therapy and resistance in estrogen receptor positive (ER+) breast cancer models

10.1158/1538-7445.am2015-lb-166 ◽

2015 ◽

Author(s):

Agostina Nardone ◽

Amit Goldstein ◽

Martin J. Shea ◽

Tamika Mithchell ◽

Xiaoyong Fu ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Endocrine Therapy ◽

Parp Inhibition ◽

Cancer Models ◽

Estrogen Receptor Positive

Download Full-text

Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor–Positive Breast Cancer Models with a Distinct Mechanism of Action

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-0670 ◽

2017 ◽

Vol 23 (24) ◽

pp. 7608-7620 ◽

Author(s):

Ziyang Yu ◽

Suqin He ◽

Dannie Wang ◽

Hitisha K. Patel ◽

Chris P. Miller ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Androgen Receptor ◽

Mechanism Of Action ◽

Selective Androgen Receptor Modulator ◽

Receptor Modulator ◽

Distinct Mechanism ◽

Cancer Models ◽

Estrogen Receptor Positive ◽

Positive Breast Cancer

Download Full-text